Press

Together We’re Fueling the Midwest Tech Boom

Rev1 in the News

Rev1 Ventures, Ohio State partner with City of Columbus to create ‘Software Alley’
Rev1 News
Rev1 Ventures, Ohio State partner with City of Columbus to create ‘Software Alley’
How to Use Milestone Mapping to Chart a Path for Startup Growth
Rev1 News
How to Use Milestone Mapping to Chart a Path for Startup Growth
Kristy Campbell is driven to help startups
Rev1 News
Kristy Campbell is driven to help startups
50 Columbus-Based Startups on Display at Annual Innovation Hop
Rev1 News
50 Columbus-Based Startups on Display at Annual Innovation Hop
Rev1’s Innovation Hop: Bold startups. Big ideas. One night only.
Rev1 News
Rev1’s Innovation Hop: Bold startups. Big ideas. One night only.
Load More

Buzz About Our Companies

HealthPlan Data Solutions Rebrands as Rivera, Unveiling a Bold New Era of PBM Oversight
Company News
HealthPlan Data Solutions Rebrands as Rivera, Unveiling a Bold New Era of PBM Oversight
Basking Biosciences Doses First Patients in Part B of Phase 2 Stroke Trial, Unlocks $27.5 Million Financing Tranche, and Appoints Julia C. Owens, Ph.D. as Chief Executive Officer
Company News, Funding News
Basking Biosciences Doses First Patients in Part B of Phase 2 Stroke Trial, Unlocks $27.5 Million Financing Tranche, and Appoints Julia C. Owens, Ph.D. as Chief Executive Officer
71/70 Angels, Interview With Managing Director Melinda Gloriosa
Company News
71/70 Angels, Interview With Managing Director Melinda Gloriosa
Neucore Bio Awarded Competitive Grant from the U.S. National Science Foundation for Research on Scalability of Exosome-based Therapeutics for Genetic Disease
Company News, Funding News
Neucore Bio Awarded Competitive Grant from the U.S. National Science Foundation for Research on Scalability of Exosome-based Therapeutics for Genetic Disease
Neucore Bio Awarded Competitive Grant from the U.S. National Science Foundation for Research on Scalability of Exosome-based Therapeutics for Genetic Disease
Company News
Neucore Bio Awarded Competitive Grant from the U.S. National Science Foundation for Research on Scalability of Exosome-based Therapeutics for Genetic Disease
Load More

Accolades

Pitchbook
Pitchbook: #1 Most Active VC in Ohio

2014 – 2018

cbinsights
CB Insights: #1 Most Active VC in Ohio

2014 – 2018

Pitchbook
Pitchbook: #2 Most Active VC in the Great Lakes

2017 – 2018

Pitchbook
Pitchbook: #9 Most Active Angel & Seed Investor in United States

2018

SSTI
SSTi: Excellence in Technology Based Economic Development Award

2012 – Increasing Access to Capital

Pitchbook
Pitchbook: #1 Most Active VC in Ohio

2014 – 2018

cbinsights
CB Insights: #1 Most Active VC in Ohio

2014 – 2018

Pitchbook
Pitchbook: #2 Most Active VC in the Great Lakes

2017 – 2018

Pitchbook
Pitchbook: #9 Most Active Angel & Seed Investor in United States

2018

SSTI
SSTi: Excellence in Technology Based Economic Development Award

2012 – Increasing Access to Capital

Press Inquiries?

For media inquiries or introductions to any of our portfolio clients, contact Ashley Baig, Director of Marketing and Communications.

Email Ashley